Pricing

Oscient Pharmaceuticals Corp. (OSCIQ)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
1000 WINTER STREET WALTHAM, MA 02451

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • GENOME THERAPEUTICS CORP
Stock Split History
DateRatio
2006-11-16 1:8
Oscient Pharm operates as a commercial-stage biopharmaceutical company that focuses on expanding its business in the primary care physician marketplace in the U.S. The company's lead product is FACTIVE, a treatment for pneumonia and bronchitis.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available